EP Patent

EP2114934A1 — Composition and methods for modulating a kinase cascade

Assigned to Athenex Inc · Expires 2009-11-11 · 17y expired

What this patent protects

The invention relates to compositions of N-benzyl-2-(5-(4-(2- morpholinoethoxy)phenyl)pyridin-2-yl)acetamide (KX2-391) and methods for modulating one or more components of a kinase cascade.

USPTO Abstract

The invention relates to compositions of N-benzyl-2-(5-(4-(2- morpholinoethoxy)phenyl)pyridin-2-yl)acetamide (KX2-391) and methods for modulating one or more components of a kinase cascade.

Drugs covered by this patent

Patent Metadata

Patent number
EP2114934A1
Jurisdiction
EP
Classification
—
Expires
2009-11-11
Drug substance claim
No
Drug product claim
No
Assignee
Athenex Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.